Literature DB >> 8274113

Tuberous sclerosis in Western Sweden. A population study of cases with early childhood onset.

G Ahlsén1, I C Gillberg, R Lindblom, C Gillberg.   

Abstract

OBJECTIVE: To study the prevalence of tuberous sclerosis in children and adolescents.
DESIGN: Previously published diagnostic criteria for tuberous sclerosis were used. All physicians likely to encounter young patients with tuberous sclerosis were contacted by way of a screening questionnaire.
SETTING: The study was performed in a circumscribed geographic area (western Sweden). PATIENTS AND OTHER PARTICIPANTS: The sample was population based. However, only patients with such severe and early symptoms that referral to a physician had been considered necessary and relatives of these patients with tuberous sclerosis could be included. This was because there is currently no diagnostic marker for tuberous sclerosis that could be used as a screening tool.
RESULTS: The peak prevalence (one in 6800 individuals) for tuberous sclerosis was found in the 11- to 15-year-old age group. For the whole age cohort, 0 to 20 years, the prevalence was one in 12,900 individuals.
CONCLUSIONS: The prevalence for the school-age group was the highest ever reported in the literature on tuberous sclerosis. However, it is likely that the true prevalence of tuberous sclerosis in the general population is even higher.

Entities:  

Mesh:

Year:  1994        PMID: 8274113     DOI: 10.1001/archneur.1994.00540130110018

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  13 in total

1.  Complete inactivation of the TSC2 gene leads to formation of hamartomas.

Authors:  K S Au; A A Hebert; E S Roach; H Northrup
Journal:  Am J Hum Genet       Date:  1999-12       Impact factor: 11.025

2.  Report of a critical recombination further narrowing the TSC1 region.

Authors:  K S Au; J Murrell; A Buckler; S H Blanton; H Northrup
Journal:  J Med Genet       Date:  1996-07       Impact factor: 6.318

3.  Cardiac rhabdomyomas associated with tuberous sclerosis complex in children. From presentation to outcome.

Authors:  Q Shen; J Shen; Z Qiao; Q Yao; G Huang; X Hu
Journal:  Herz       Date:  2014-03-09       Impact factor: 1.443

Review 4.  Tuberous sclerosis.

Authors:  D W Webb; J P Osborne
Journal:  Arch Dis Child       Date:  1995-06       Impact factor: 3.791

5.  Tuberous sclerosis and cardiac tumors: new electrocardiographic finding in an infant.

Authors:  Eyup Aslan; Fatih Sap; Ahmet Sert; Dursun Odabas
Journal:  Tex Heart Inst J       Date:  2014-10-01

Review 6.  Neurologic manifestations of tuberous sclerosis complex.

Authors:  William M McClintock
Journal:  Curr Neurol Neurosci Rep       Date:  2002-03       Impact factor: 5.081

Review 7.  Epidemiological surveys of autism and other pervasive developmental disorders: an update.

Authors:  Eric Fombonne
Journal:  J Autism Dev Disord       Date:  2003-08

8.  Monoallelic germline TSC1 mutations are permissive for T lymphocyte development and homeostasis in tuberous sclerosis complex individuals.

Authors:  Karolina Pilipow; Veronica Basso; Nicola Migone; Anna Mondino
Journal:  PLoS One       Date:  2014-03-14       Impact factor: 3.240

9.  Self-injury and aggression in tuberous sclerosis complex: cross syndrome comparison and associated risk markers.

Authors:  Kate E Eden; Petrus J de Vries; Jo Moss; Caroline Richards; Chris Oliver
Journal:  J Neurodev Disord       Date:  2014-05-10       Impact factor: 4.025

10.  Everolimus safety and efficacy for renal angiomyolipomas associated with tuberous sclerosis complex: a Spanish expanded access trial.

Authors:  Nicolás Roberto Robles; Ramón Peces; Álvaro Gómez-Ferrer; Felipe Villacampa; Jose Luis Álvarez-Ossorio; Pedro Pérez-Segura; Juan Morote; Bernardo Herrera-Imbroda; Javier Nieto; Joaquín Carballido; Urbano Anido; Marian Valero; Cristina Meseguer; Roser Torra
Journal:  Orphanet J Rare Dis       Date:  2016-09-26       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.